{
    "clinical_study": {
        "@rank": "28603", 
        "acronym": "ART", 
        "brief_summary": {
            "textblock": "This is a single arm, single centre imaging study which will be offered to all consecutive,\n      eligible patients receiving radical chemoradiation therapy (CRT) for anal cancer within\n      Oxford University Hospitals. Hypothesising that patients with no resolution of poor\n      vascularity or hypoxia, correlate with those likely to be at risk of relapse; and half of\n      those patients could be identified with this technique, we would anticipate at least 3 of 16\n      patients to demonstrate minimal change in Apparent diffusion coefficient (ADC).\n\n      Investigations\n\n        -  Dynamic contrast enhanced magnetic resonance imaging (DCE MRI)\n\n        -  Diffusion weighted magnetic resonance imaging (DWI MRI)\n\n        -  Blood oxygen-dependent magnetic resonance imaging (BOLD MRI)\n\n        -  Perfusion computed tomography (pCT)\n\n        -  Fludeoxyglucose positron emission tomography (FDG PET/CT)\n\n      Study Design: Observational\n\n      Patient Numbers: 16 evaluable patients\n\n      Target Population: Patients undergoing radical CRT for anal cancer in Oxford University\n      Hospitals National Health Service (NHS) Trust.\n\n      Duration on study: Patients should be on study for a maximum of 5 months.\n\n      Patient care post-trial: Follow up as per local standard.\n\n      No. of Study Site(s): Single Centre, United Kingdon (UK)\n\n      End of study: Last Patient, last assessment of response. Patients should be on study for a\n      maximum of 5 months."
        }, 
        "brief_title": "ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy", 
        "completion_date": {
            "#text": "February 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Anal Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Anus Neoplasms", 
                "Carcinoma", 
                "Carcinoma, Squamous Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically confirmed invasive primary squamous carcinoma of the anus.\n\n          -  Patients must be fit and scheduled to receive radical CRT with curative intent.\n\n          -  Any stage tumor 2-node 0 (T2N0)\n\n          -  Male or female, Age 18 years+.\n\n          -  The patient is willing and able to comply with the images and protocol for the\n             duration of the study\n\n          -  Written (signed and dated) informed consent and be capable of co-operating with\n             protocol.\n\n        Exclusion Criteria:\n\n          -  Pregnant or breast-feeding women or women of childbearing potential unless effective\n             methods of contraception are used.\n\n          -  Previous  pelvic radiotherapy\n\n          -  Patients with a pacemaker or any other implanted metal which would preclude MRI scan.\n\n          -  Patients receiving radiotherapy with palliative intent.\n\n          -  Active medical or psychological illness that would render the patient unsuitable for\n             the additional imaging proposed in this study, at the discretion of the investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Eligible patients receiving radical CRT for anal cancer within Oxford University Hospitals"
            }
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02145416", 
            "org_study_id": "OCTO-051"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Imaging", 
            "Chemoradiotherapy"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "link": {
            "description": "Oncology Clinical Trials Office homepage", 
            "url": "http://octo-oxford.org.uk"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Oxford", 
                    "country": "United Kingdom", 
                    "zip": "OX3 7LE"
                }, 
                "name": "Churchill Hospital"
            }, 
            "investigator": {
                "last_name": "Rebecca Muirhead, MBChB, MRCP, FRCR, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "official_title": "Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy", 
        "overall_contact": {
            "email": "naomi.mcgregor@oncology.ox.ac.uk", 
            "last_name": "Naomi McGregor, PhD", 
            "phone": "01865 227192"
        }, 
        "overall_contact_backup": {
            "email": "claire.brooks@oncology.ox.ac.uk", 
            "last_name": "Claire Brooks, MSc", 
            "phone": "01865 227161"
        }, 
        "overall_official": {
            "affiliation": "Oxford University Hospitals NHS Trust", 
            "last_name": "Rebecca Muirhead, MBCHB, MRCP, FRCR, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The number of patients with a change in ADC values of <20% between pre-CRT DW MRI and repeat DW MRI following 8-10 fractions of CRT", 
            "measure": "Changes on DW MRI during CRT in anal cancer.", 
            "safety_issue": "No", 
            "time_frame": "Fraction 8-10 of CRT (Day 10-12) compared with prior to CRT (Day 1)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02145416"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Changes on alternative functional imaging modalities following 8-10 fractions of CRT:\nDCE MRI - Change in amplitude and rate of gadolinium enhancement.\nPerfusion CT - Changes in perfusion maps represented by blood flow, blood volume, mean transition time and permeability surface area.\nBOLD MRI - Change in hypoxic regions (R2 value).\nFDG PET - Change in tumour uptake (% change in SUVmax).", 
                "measure": "Changes on DCE MRI, Perfusion CT, BOLD MRI, FDG PET", 
                "safety_issue": "No", 
                "time_frame": "Fraction 8-10 of CRT (Day 10-12)"
            }, 
            {
                "description": "Correlate size and position of regions of poor vascularity / hypoxia between different images at the same timepoint using volume, centre of mass and overlap comparisons.", 
                "measure": "Correlation of findings on different functional images.", 
                "safety_issue": "No", 
                "time_frame": "Both prior to CRT day 1 and fraction 8-10"
            }, 
            {
                "description": "Compare volumes of poor vascularity / hypoxia in baseline scans (as described above) with complete response rates 3 months after CRT.", 
                "measure": "Correlation of baseline functional images with outcome of CRT", 
                "safety_issue": "No", 
                "time_frame": "3 months post CRT  compared with prior to CRT (Day 1)"
            }, 
            {
                "description": "Change in volumes of poor vascularity / hypoxia in baseline scans (as described above) with complete response rates 3 months after CRT.", 
                "measure": "Correlation of the change in functional images over CRT with outcome of CRT", 
                "safety_issue": "No", 
                "time_frame": "3 months post CRT"
            }
        ], 
        "source": "University of Oxford", 
        "sponsors": {
            "collaborator": {
                "agency": "Oxford University Hospitals NHS Trust", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Oxford", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}